These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818 [TBL] [Abstract][Full Text] [Related]
45. Immunity, inflammation, and allergy in the gut. Macdonald TT; Monteleone G Science; 2005 Mar; 307(5717):1920-5. PubMed ID: 15790845 [TBL] [Abstract][Full Text] [Related]
46. Epithelial barriers in intestinal inflammation. John LJ; Fromm M; Schulzke JD Antioxid Redox Signal; 2011 Sep; 15(5):1255-70. PubMed ID: 21294654 [TBL] [Abstract][Full Text] [Related]
47. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Vereecke L; Beyaert R; van Loo G Trends Mol Med; 2011 Oct; 17(10):584-93. PubMed ID: 21741311 [TBL] [Abstract][Full Text] [Related]
48. Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury. Wang J; Hauer-Jensen M Br J Radiol; 2007 Sep; 80 Spec No 1():S41-8. PubMed ID: 17704325 [TBL] [Abstract][Full Text] [Related]
49. Intestinal barrier homeostasis in inflammatory bowel disease. Goll R; van Beelen Granlund A Scand J Gastroenterol; 2015 Jan; 50(1):3-12. PubMed ID: 25523551 [TBL] [Abstract][Full Text] [Related]
50. The intestinal epithelial barrier in the control of homeostasis and immunity. Rescigno M Trends Immunol; 2011 Jun; 32(6):256-64. PubMed ID: 21565554 [TBL] [Abstract][Full Text] [Related]
51. Role of programmed necrosis and cell death in intestinal inflammation. Dagenais M; Douglas T; Saleh M Curr Opin Gastroenterol; 2014 Nov; 30(6):566-75. PubMed ID: 25291357 [TBL] [Abstract][Full Text] [Related]
52. Enteric glial cells: recent developments and future directions. Neunlist M; Rolli-Derkinderen M; Latorre R; Van Landeghem L; Coron E; Derkinderen P; De Giorgio R Gastroenterology; 2014 Dec; 147(6):1230-7. PubMed ID: 25305504 [TBL] [Abstract][Full Text] [Related]
53. Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome. Santos J; Alonso C; Vicario M; Ramos L; Lobo B; Malagelada JR Curr Mol Med; 2008 Jun; 8(4):258-73. PubMed ID: 18537634 [TBL] [Abstract][Full Text] [Related]
54. The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease. Deuring JJ; de Haar C; Kuipers EJ; Peppelenbosch MP; van der Woude CJ Int J Biochem Cell Biol; 2013 Apr; 45(4):798-806. PubMed ID: 23291352 [TBL] [Abstract][Full Text] [Related]
55. The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function in health and disease. Meir M; Flemming S; Burkard N; Wagner J; Germer CT; Schlegel N Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1118-23. PubMed ID: 27151942 [TBL] [Abstract][Full Text] [Related]
56. Leaky gut - concept or clinical entity? Quigley EM Curr Opin Gastroenterol; 2016 Mar; 32(2):74-9. PubMed ID: 26760399 [TBL] [Abstract][Full Text] [Related]
57. Good bug, bad bug: in the case of enteric inflammatory disease does the epithelium decide? McKay DM Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():205-10. PubMed ID: 15962124 [TBL] [Abstract][Full Text] [Related]
58. Intestinal permeability--a new target for disease prevention and therapy. Bischoff SC; Barbara G; Buurman W; Ockhuizen T; Schulzke JD; Serino M; Tilg H; Watson A; Wells JM BMC Gastroenterol; 2014 Nov; 14():189. PubMed ID: 25407511 [TBL] [Abstract][Full Text] [Related]
59. Immune-non immune networks in intestinal inflammation. Hausmann M; Rogler G Curr Drug Targets; 2008 May; 9(5):388-94. PubMed ID: 18473767 [TBL] [Abstract][Full Text] [Related]